Literature DB >> 21743017

Prediction, by retinal location, of the onset of diabetic edema in patients with nonproliferative diabetic retinopathy.

Wendy W Harrison1, Marcus A Bearse, Marilyn E Schneck, Brian E Wolff, Nicholas P Jewell, Shirin Barez, Andrew B Mick, Bernard J Dolan, Anthony J Adams.   

Abstract

PURPOSE: To formulate a model to predict the location of the onset of diabetic retinal edema (DE) in adults with diabetic retinopathy (DR), at risk for DE.
METHODS: In all, 46 eyes from 23 patients with DR were included. Subjects were followed semiannually until DE developed or the study concluded. The presence or absence of DE within the central 45 ° at the final visit was the outcome measure, and data from the prior visit were used as baseline. A logistic regression model was formulated to assess the relationship between DE development and: multifocal electroretinogram (mfERG) implicit time (IT) Z-score, mfERG amplitude (Amp) Z-score, sex, diabetes duration, diabetes type, blood glucose, HbA1c, age, systolic (SBP) and diastolic blood pressure, and grade of retinopathy. A total of 35 retinal zones were constructed from the mfERG elements and each was graded for DE. Data from 52 control subjects were used to calculate the maximum IT and minimum Amp Z-scores for each zone. Receiver operating characteristic curves from a fivefold cross-validation were used to determine the model's predictive properties.
RESULTS: Edema developed in 5.2% of all retinal zones and in 35% of the eyes. The mfERG Amp, mfERG IT, SBP, and sex were together predictive of edema onset. Combined, these factors produce a model that has 84% sensitivity and 76% specificity.
CONCLUSIONS: Together mfERG, SBP, and sex are good predictors of local edema in patients with DR. The model is a useful tool for assessing risk for edema development and a candidate measure to evaluate novel therapeutics directed at DE.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21743017      PMCID: PMC3176012          DOI: 10.1167/iovs.11-7533

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  43 in total

1.  Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.

Authors:  Michael J Elman; Lloyd Paul Aiello; Roy W Beck; Neil M Bressler; Susan B Bressler; Allison R Edwards; Frederick L Ferris; Scott M Friedman; Adam R Glassman; Kellee M Miller; Ingrid U Scott; Cynthia R Stockdale; Jennifer K Sun
Journal:  Ophthalmology       Date:  2010-04-28       Impact factor: 12.079

2.  Retinal vascular fractals and microvascular and macrovascular complications in type 1 diabetes.

Authors:  Jakob Grauslund; Anders Green; Ryo Kawasaki; Lauren Hodgson; Anne Katrin Sjølie; Tien Y Wong
Journal:  Ophthalmology       Date:  2010-02-21       Impact factor: 12.079

3.  A severity scale for diabetic macular edema developed from ETDRS data.

Authors:  Ronald E Gangnon; Matthew D Davis; Larry D Hubbard; Lloyd M Aiello; Emily Y Chew; Frederick L Ferris; Marian R Fisher
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-06       Impact factor: 4.799

Review 4.  A review of clinical trials of anti-VEGF agents for diabetic retinopathy.

Authors:  Benjamin P Nicholson; Andrew P Schachat
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-20       Impact factor: 3.117

5.  Intravitreal combination of triamcinolone acetonide and bevacizumab (Kenacort-Avastin) in diffuse diabetic macular edema.

Authors:  Miltiadis K Tsilimbaris; Vassilios Pandeleondidis; Theoni Panagiototglou; Vassiliki Arvanitaki; Sofia Fragiskou; Maria Eleftheriadou; Chrysanthi Tsika; Theokliti Papadaki
Journal:  Semin Ophthalmol       Date:  2009 Nov-Dec       Impact factor: 1.975

6.  Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial.

Authors:  J W J Beulens; A Patel; J R Vingerling; J K Cruickshank; A D Hughes; A Stanton; J Lu; S A McG Thom; D E Grobbee; R P Stolk
Journal:  Diabetologia       Date:  2009-07-25       Impact factor: 10.122

7.  Multifocal electroretinography amplitudes increase after photocoagulation in areas with increased retinal thickness and hard exudates.

Authors:  Monica Lövestam-Adrian; Kristina Holm
Journal:  Acta Ophthalmol       Date:  2009-02-07       Impact factor: 3.761

8.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes.

Authors:  Ronald Klein; Michael D Knudtson; Kristine E Lee; Ronald Gangnon; Barbara E K Klein
Journal:  Ophthalmology       Date:  2009-01-22       Impact factor: 12.079

9.  Ethnicity, race, and clinically significant macular edema in the Veterans Affairs Diabetes Trial (VADT).

Authors:  Nicholas Emanuele; Thomas Moritz; Ronald Klein; Matthew D Davis; Kathleen Glander; Anuradha Khanna; Lizy Thottapurathu; Gideon Bahn; William Duckworth; Carlos Abraira
Journal:  Diabetes Res Clin Pract       Date:  2009-08-31       Impact factor: 5.602

10.  Reproducibility of the mfERG between instruments.

Authors:  Wendy W Harrison; Marcus A Bearse; Jason S Ng; Shirin Barez; Marilyn E Schneck; Anthony J Adams
Journal:  Doc Ophthalmol       Date:  2009-03-26       Impact factor: 2.379

View more
  15 in total

Review 1.  Retinal Failure in Diabetes: a Feature of Retinal Sensory Neuropathy.

Authors:  Ellyn J Gray; Thomas W Gardner
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

Review 2.  Multifocal electroretinography in diabetic retinopathy and diabetic macular edema.

Authors:  Marcus A Bearse; Glen Y Ozawa
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

3.  Association between local neuroretinal function and control of adolescent type 1 diabetes.

Authors:  Michal Laron; Marcus A Bearse; Kevin Bronson-Castain; Soffia Jonasdottir; Barbara King-Hooper; Shirin Barez; Marilyn E Schneck; Anthony J Adams
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-09       Impact factor: 4.799

4.  Associations between local retinal thickness and function in early diabetes.

Authors:  Kavita P Dhamdhere; Marcus A Bearse; Wendy Harrison; Shirin Barez; Marilyn E Schneck; Anthony J Adams
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-12       Impact factor: 4.799

5.  Central Macular Thickness in Diabetic Patients: A Sex-based Analysis.

Authors:  Edmund Arthur; Stuart B Young; Ann E Elsner; Karthikeyan Baskaran; Joel A Papay; Matthew S Muller; Thomas J Gast; Bryan P Haggerty; Christopher A Clark; Victor E Malinovsky; Shane G Brahm; Taras V Litvin; Glen Y Ozawa; Jorge A Cuadros
Journal:  Optom Vis Sci       Date:  2019-04       Impact factor: 1.973

6.  Neurodegenerative differences in the retinas of male and female patients with type 2 diabetes.

Authors:  Glen Y Ozawa; Marcus A Bearse; Kevin W Bronson-Castain; Wendy W Harrison; Marilyn E Schneck; Shirin Barez; Anthony J Adams
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-17       Impact factor: 4.799

7.  Color vision and neuroretinal function in diabetes.

Authors:  B E Wolff; M A Bearse; M E Schneck; K Dhamdhere; W W Harrison; S Barez; A J Adams
Journal:  Doc Ophthalmol       Date:  2014-12-17       Impact factor: 2.379

Review 8.  Diabetic retinopathy: current understanding, mechanisms, and treatment strategies.

Authors:  Elia J Duh; Jennifer K Sun; Alan W Stitt
Journal:  JCI Insight       Date:  2017-07-20

Review 9.  Arginase in retinopathy.

Authors:  S Priya Narayanan; Modesto Rojas; Jutamas Suwanpradid; Haroldo A Toque; R William Caldwell; Ruth B Caldwell
Journal:  Prog Retin Eye Res       Date:  2013-07-03       Impact factor: 21.198

Review 10.  Early microvascular complications in type 1 and type 2 diabetes: recent developments and updates.

Authors:  Kalie L Tommerdahl; Allison L B Shapiro; Edward J Nehus; Petter Bjornstad
Journal:  Pediatr Nephrol       Date:  2021-04-14       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.